Meissner
Manufacturer of filtration and single-use systems for pharmaceutical and biopharmaceutical production. Offers hollow-fiber tangential flow filtration cartridges, single-use biocontainers and filling assemblies, mixing systems, and freeze/thaw platforms. Operates global manufacturing sites and cleanroom facilities and provides technical services, application engineering, membrane characterization, and validated process support for GMP manufacturing and supply-chain resilience.
Industries
Nr. of Employees
medium (51-250)
Patents
Products
Hollow-fiber tangential flow filter cartridges
Hollow-fiber cartridges for microfiltration and ultrafiltration available in a range of retention ratings and sizes for pilot to production scale.
Single-use biocontainers and filling/transfer assemblies
Single-use container systems and aseptic filling/transfer assemblies designed for aseptic handling, sampling, and integration into single-use workflows.
Freeze and thaw platforms for bulk drug substance
Controlled freezing/thawing systems and associated insulated shipping and material handling designed to maintain integrity of bulk drug substance at various scales.
Single-use mixing assemblies and rotary impeller mixing solutions
Mixing assemblies for biocontainers including rotary impeller and recirculation mixing options designed for rapid homogeneous mixing and powder hydration.
Hollow-fiber tangential flow filter cartridges
Hollow-fiber cartridges for microfiltration and ultrafiltration available in a range of retention ratings and sizes for pilot to production scale.
Single-use biocontainers and filling/transfer assemblies
Single-use container systems and aseptic filling/transfer assemblies designed for aseptic handling, sampling, and integration into single-use workflows.
Freeze and thaw platforms for bulk drug substance
Controlled freezing/thawing systems and associated insulated shipping and material handling designed to maintain integrity of bulk drug substance at various scales.
Single-use mixing assemblies and rotary impeller mixing solutions
Mixing assemblies for biocontainers including rotary impeller and recirculation mixing options designed for rapid homogeneous mixing and powder hydration.
Services
Technical application engineering for single-use systems, filtration, mixing, and freeze/thaw workflows; process optimization and implementation support.
Laboratory testing, membrane characterization, and validation services to support product qualification and process validation.
Technical application engineering for single-use systems, filtration, mixing, and freeze/thaw workflows; process optimization and implementation support.
Laboratory testing, membrane characterization, and validation services to support product qualification and process validation.
Expertise Areas
- Filtration and tangential flow filtration
- Ultrafiltration membrane characterization
- Single-use systems development (biocontainers, assemblies)
- Mixing and agitation systems for single-use containers
Key Technologies
- Hollow-fiber tangential flow filtration
- Ultrafiltration and microfiltration membranes
- Single-use biocontainer film platforms (polyolefin and fluoropolymer)
- Aseptic single-use filling and transfer assemblies
News & Updates
Opening of a dedicated office in Solaris @ one-north, Singapore to extend presence and operations in the Asia-Pacific region.
Investment of nearly $250 million for a new manufacturing facility in Athens, GA with plans for cleanrooms, laboratories, R&D, and creation of approximately 1,700 jobs.
Acquisition and buildout of production facilities in Castlebar, Ireland to support single-use system manufacturing and cleanroom operations.
Publication of a sustainability report addressing material sustainability issues and associated metrics and goals.
Discussion of a shift to multi-marker membrane characterization and reported case-study performance improvements in cell and gene therapy workflows.
Co-development and commercialization of a scalable single-use freeze/thaw platform for bulk drug substance with validated integrity and shipping performance.
Opening of a dedicated office in Solaris @ one-north, Singapore to extend presence and operations in the Asia-Pacific region.
Investment of nearly $250 million for a new manufacturing facility in Athens, GA with plans for cleanrooms, laboratories, R&D, and creation of approximately 1,700 jobs.
Acquisition and buildout of production facilities in Castlebar, Ireland to support single-use system manufacturing and cleanroom operations.
Publication of a sustainability report addressing material sustainability issues and associated metrics and goals.
Discussion of a shift to multi-marker membrane characterization and reported case-study performance improvements in cell and gene therapy workflows.
Co-development and commercialization of a scalable single-use freeze/thaw platform for bulk drug substance with validated integrity and shipping performance.